82 related articles for article (PubMed ID: 37453621)
1. Based on network pharmacology and experiments to explore the underlying mechanism of Mahonia bealei (Fortune) Carrière for treating alcoholic hepatocellular carcinoma.
Zhang N; Zhu Y; Zhang X; Yang K; Yang X; An M; Tian C; Li J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116919. PubMed ID: 37453621
[TBL] [Abstract][Full Text] [Related]
2. A Strategy based on Bioinformatics and Machine Learning Algorithms Reveals Potential Mechanisms of Shelian Capsule against Hepatocellular Carcinoma.
Zhou X; Tan F; Zhang S; Wang A; Zhang T
Curr Pharm Des; 2024; 30(5):377-405. PubMed ID: 38310567
[TBL] [Abstract][Full Text] [Related]
3. Investigating the molecular mechanism of Qizhu anticancer prescription in inhibiting hepatocellular carcinoma based on high-resolution mass spectrometry and network pharmacology.
Sun J; Ma M; Zhong X; Li J; Yi J; Zhang R; Liu X; Peng L; Sun X; Feng W; Hu R; Huang Q; Lv M; Fan K; Zhou X
J Ethnopharmacol; 2024 Jun; 328():117985. PubMed ID: 38417600
[TBL] [Abstract][Full Text] [Related]
4. In silico and network pharmacology analysis of fucosterol: a potent anticancer bioactive compound against HCC.
Singh K; Kumar P; Singh AK; Singh N; Singh S; Tiwari KN; Agrawal S; Das R; Singh A; Ram B; Tripathi AK; Mishra SK
Med Oncol; 2024 Apr; 41(6):130. PubMed ID: 38676780
[TBL] [Abstract][Full Text] [Related]
5. Identification of formononetin as the active compound of CR-SR in hepatocellular carcinoma treatment: An integrated approach combining network pharmacology and weighted gene co-expression networks.
Li C; Xie Y; Hu S; Yu H; Xu Y; Shen H; Yuan Y; Gu L; Pu B
Chem Biol Drug Des; 2024 Jan; 103(1):e14363. PubMed ID: 37793997
[TBL] [Abstract][Full Text] [Related]
6. Predicting the potential mechanism of radix chimonanthi pracecocis in treating osteoarthritis by network pharmacology analysis combined with experimental validation.
Zhang X; Wu D; Zhang L; Zhang H; Yang L; Wei L; Mei H; Luo L; Jiang Z; Huang C
J Ethnopharmacol; 2024 May; 331():118231. PubMed ID: 38718891
[TBL] [Abstract][Full Text] [Related]
7. Integrated analyses for identification of a three-gene signature associated with Chaihu Shugan San formula for hepatocellular carcinoma treatment.
Xing JH; Tan RX; Huang FE; Tian N
J Cell Mol Med; 2024 Apr; 28(8):e18211. PubMed ID: 38613352
[TBL] [Abstract][Full Text] [Related]
8. [Study on mechanism of icariin-induced ferroptosis in HepG2 hepatoma carcinoma cells through PPARG/FABP4/GPX4 pathway].
Li L; Zeng PH; Yang RY; Deng Y; He ZM; Xia X; Zhu DY; Peng QH
Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1295-1309. PubMed ID: 38621977
[TBL] [Abstract][Full Text] [Related]
9. Exosome-Related FTCD Facilitates M1 Macrophage Polarization and Impacts the Prognosis of Hepatocellular Carcinoma.
Liu Y; Tang Y; Jiang H; Zhang X; Chen X; Guo J; Jin C; Wu M
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254641
[TBL] [Abstract][Full Text] [Related]
10. Investigating the effect of polymerase inhibitors on cellular proliferation: Computational studies, cytotoxicity, CDK1 inhibitory potential, and LC-MS/MS cancer cell entrapment assays.
Farouk F; Ibrahim IM; Sherif S; Abdelhamed HG; Sharaky M; Al-Karmalawy AA
Chem Biol Drug Des; 2024 Mar; 103(3):e14500. PubMed ID: 38467555
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics.
Wan Y; Jiang H; Liu Z; Bai C; Lian Y; Zhang C; Zhang Q; Huang J
Curr Pharm Des; 2024 May; ():. PubMed ID: 38747231
[TBL] [Abstract][Full Text] [Related]
12. Nitidine chloride inhibits G2/M phase by regulating the p53/14-3-3 Sigma/CDK1 axis for hepatocellular carcinoma treatment.
Zhang B; Zhou B; Huang G; Huang J; Lin X; Li Z; Lian Y; Huang Q; Ye Y
Heliyon; 2024 Jan; 10(1):e24012. PubMed ID: 38283241
[TBL] [Abstract][Full Text] [Related]
13. Screening and Identification of ESR1 as a Target of Icaritin in Hepatocellular Carcinoma: Evidence from Bibliometrics and Bioinformatic Analysis.
Zhou Y; Gu J; Yu H; Chen F; Long C; Maihemuti M; Chen T; Zhang W
Curr Mol Pharmacol; 2023 Oct; ():. PubMed ID: 38239068
[TBL] [Abstract][Full Text] [Related]
14. Integrated virtual screening and MD simulation approaches toward discovering potential inhibitors for targeting BRPF1 bromodomain in hepatocellular carcinoma.
Barman S; Bardhan I; Padhan J; Sudhamalla B
J Mol Graph Model; 2024 Jan; 126():108642. PubMed ID: 37797430
[TBL] [Abstract][Full Text] [Related]
15. Network-base approaches to identify therapeutic biomarkers in hepatocellular carcinoma and search for drug hunting utilizing molecular dynamics simulations.
Ayaz H; Ahmad F; Ahmad S; Arfan Q; Alasmari AF; Siddique F; Rehman B; Zeb A; Crovella S; Ali SS; Waheed Y; Suleman M
J Biomol Struct Dyn; 2024 Mar; ():1-17. PubMed ID: 38486461
[TBL] [Abstract][Full Text] [Related]
16. Computational identification of potential bioactive compounds from Triphala against alcoholic liver injury by targeting alcohol dehydrogenase.
Banjan B; Raju R; Keshava Prasad TS; Abhinand CS
Mol Divers; 2024 May; ():. PubMed ID: 38743308
[TBL] [Abstract][Full Text] [Related]
17. Jingfang granule alleviates Pseudomonas aeruginosa-induced acute lung inflammation through suppression of STAT3/IL-17/NF-κB pathway based on network pharmacology analysis and experimental validation.
Gu M; Su W; Dai J; Wang J; Jia X; Yao J; Zhang G; Zhu Q; Pang Z
J Ethnopharmacol; 2024 Jan; 318(Pt A):116899. PubMed ID: 37454750
[TBL] [Abstract][Full Text] [Related]
18. Quality control assessment, toxicity profiling, and experimental validation of network pharmacology-predicted anti-inflammatory potential of Natsiatum herpeticum Buch.-Ham. Ex Arn.
Hazarika S; Hemalatha S
J Ethnopharmacol; 2024 Jan; 318(Pt A):116902. PubMed ID: 37453628
[TBL] [Abstract][Full Text] [Related]
19. Extraction, purification, structural characteristics and biological properties of the polysaccharides from Radix Saposhnikoviae: A review.
Rao Z; Zhou H; Li Q; Zeng N; Wang Q
J Ethnopharmacol; 2024 Jan; 318(Pt A):116956. PubMed ID: 37487960
[TBL] [Abstract][Full Text] [Related]
20. Jingfang Granules () alleviates bleomycin-induced acute lung injury through regulating PI3K/Akt/mTOR signaling pathway.
Sun X; Xiang H; Liu Z; Xiao H; Li X; Gong W; Pan L; Zhao L; Yao J; Sun C; Zhang G
J Ethnopharmacol; 2024 Jan; 318(Pt A):116946. PubMed ID: 37482261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
